Trialssemaglutidetirzepatidetufts universityweight maintenance

Tufts registers trial of digital program for weight maintenance after GLP-1

The fully remote 12-month randomised study enrolls adults who recently stopped semaglutide or tirzepatide, comparing a digital lifestyle program with usual care.

By Priya Raman · Science Reporter

Oct 15 08:00 ETSource: ClinicalTrials.gov

The wire

01ClinicalTrials.gov listing NCT07701460, sponsored by Tufts University, is not yet recruiting with a start date of 15 October 2026 and no assigned phase.
02Weight regain after GLP-1 discontinuation is a recurring problem for telehealth operators and clinicians managing patients who stop therapy on cost or tolerability grounds.
03Participants get a Bluetooth scale and complete online questionnaires over a year; the registration gives no enrolment target or primary endpoint detail.

From the source

Assessing Follow up Trajectories in Eating, Routines, and Weight After GLP-1
NCT07701460 · NA · NOT YET RECRUITING · Sponsor: Tufts University · Conditions: Weight Maintenance.

Read at clinicaltrials.gov

Source URL https://clinicaltrials.gov/study/NCT07701460